Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study

Journal of Clinical Oncology - United States
doi 10.1200/jco.2005.10.167
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

High-Dose Chemotherapy in High-Risk Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2000English

Subclinical Cardiotoxicity Following Adjuvant Dose-Escalated FEC, High-Dose Chemotherapy, or CMF in Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2000English

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2018English

High-Dose Chemotherapy (CTM) for Breast Cancer

Bone Marrow Transplantation
TransplantationHematology
2000English

The Prosigna Gene Expression Assay and Responsiveness to Adjuvant Cyclophosphamide-Based Chemotherapy in Premenopausal High-Risk Patients With Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2018English

A Longitudinal Prospective Study of Health-Related Quality of Life in Breast Cancer Patients Following High-Dose Chemotherapy With Autologous Blood Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2005English

Prognostic Significance of the Immunocytochemical Detection of Contaminating Tumor Cells (CTC) in Apheresis Products of Patients With High-Risk Breast Cancer Treated With High-Dose Chemotherapy and Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2001English

The Feasibility of High-Dose Chemotherapy in Breast Cancer Patients With Impaired Left Ventricular Function

Bone Marrow Transplantation
TransplantationHematology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy